Chemical structure
Cat.No.
Product Name
CAS no.
Target
YN380092 (S)-Rasagiline 185517-74-2
(S)-Rasagiline (TVP1022) is the S-isomer of Rasagiline, which is an anti-Parkinson drug, appears to have the same neuroprotective activity as the R-isomer, but is 1000-fold less active as an MAO-B inhibitor.
YN380093 (S)-Rasagiline mesylate 202464-88-8
(S)-Rasagiline (TVP1022) mesylate is the S-isomer of rasagiline, which is an anti-Parkinson drug, appears to have the same neuroprotective activity as the R-isomer, but is 1000-fold less active as an MAO-B inhibitor.
YN380148 Safinamide mesylate 202825-46-5
Safinamide Mesylate is mesylate salt of Safinamide, selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A. Phase 3.
2614W94 is a selective, reversible inhibitor ofmonoamine oxidase-Awith a competitive mechanism of inhibition and IC50 of 5nM and Kiof 1.6nM with serotonin as substrate.
CX-157 is a reversible inhibitor ofmonoamine oxidase-A(MAO-A) with an EC50 of 19.3 ng/mL.
YN380276 Rubrofusarin triglucoside 245724-07-6
Rubrofusarin triglucoside is a glycoside compound isolated fromCassia obtusifolia Linnseeds. Rubrofusarin triglucoside inhibitshuman monoamine oxidase A (hMAO-A)with an IC50 of 85.5μM.
YN380018 (2-Chloropyridin-4-yl)methana... 916210-98-5
(2-Chloropyridin-4-yl)methanamine hydrochloride is a selectiveLOXL2inhibitor with an IC50 of 126nM.
TB5 is a potent, selective and reversible inhibitor ofhMAO-Bwith aKivalue of 0.11±0.01μM.
YN380312 MAO-B-IN-1 1124198-17-9
MAO-B-IN-1 is an inhibitor ofmonoamine oxidase B, used for the research of neurological diseases.
J147, a curcumin derivative, is a potent neurogenic and neuroprotective compound developed for the treatment of neurodegenerative conditions associated with aging.
YN380105 Rasagiline 13C3 mesylate rac... 1216757-55-9
Rasagiline 13C3 mesylate racemic is the deuterium labeled Rasagiline, which is an irreversible inhibitor of monoamine oxidase.
OG-L002 is a potent and specific LSD1 inhibitor with IC50 of 20 nM in a cell-free assay, exhibiting 36- and 69-fold selectivity over MAO-B and MAO-A, respectively.
YN380051 Vafidemstat 1357362-02-7
Vafidemstat (ORY-2001) is a dual lysine-specific histone demethylase (LSD1)/MAO-Binhibitor.
YN380032 PAT-1251 2007885-39-2
PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC5...
YN380008 GSK-LSD1 dihydrochloride 2102933-95-7
GSK-LSD1 dihydrochloride is a potent, selective and irreversible lysine specific demethylase 1 (LSD1) inhibitor with an IC50 of 16nM.
TELL : +86-020-82000279
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.
